ZANTE GREG (Chief Financial Officer) sold 39.6% of their position (97.84K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.76M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.00001 per share
Shares
+3.24K
Price / share
$7.77
Trade value
$25.19K
% of position
Common Stock, par value $0.00001 per share
Shares
+8.50K
Price / share
$4.68
Trade value
$39.78K
% of position
Common Stock, par value $0.00001 per share
Shares
+30K
Price / share
$4.88
Trade value
$146.40K
% of position
Common Stock, par value $0.00001 per share
Shares
+14.55K
Price / share
$5.80
Trade value
$84.41K
% of position
Common Stock, par value $0.00001 per share
Shares
−56.30K
Price / share
$18.00
Trade value
$1.01M
% of position
Common Stock, par value $0.00001 per share
Shares
+37.45K
Price / share
$5.80
Trade value
$217.19K
% of position
Common Stock, par value $0.00001 per share
Shares
+4.10K
Price / share
$7.77
Trade value
$31.83K
% of position
Common Stock, par value $0.00001 per share
Shares
−41.54K
Price / share
$18.00
Trade value
$747.79K
% of position
Net shares
+0.00
Net value
-$1.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 4/11/2023 | M · Option Exercise | +3.24K | $7.77 | $25.19K | 2.2% | 149.28K | 152.52K |
| Common Stock, par value $0.00001 per share Direct | 4/11/2023 | M · Option Exercise | +8.50K | $4.68 | $39.78K | 5.6% | 152.52K | 161.02K |
| Common Stock, par value $0.00001 per share Direct | 4/11/2023 | M · Option Exercise | +30K | $4.88 | $146.40K | 18.6% | 161.02K | 191.02K |
| Common Stock, par value $0.00001 per share Direct | 4/11/2023 | M · Option Exercise | +14.55K | $5.80 | $84.41K | 7.6% | 191.02K | 205.57K |
| Common Stock, par value $0.00001 per share Direct | 4/11/2023 | S · Sale | −56.30K | $18.00 | $1.01M | 27.4% | 205.57K | 149.28K |
| Common Stock, par value $0.00001 per share Direct | 4/12/2023 | M · Option Exercise | +37.45K | $5.80 | $217.19K | 25.1% | 149.28K | 186.73K |
| Common Stock, par value $0.00001 per share Direct | 4/12/2023 | M · Option Exercise | +4.10K | $7.77 | $31.83K | 2.2% | 186.73K | 190.82K |
| Common Stock, par value $0.00001 per share Direct | 4/12/2023 | S · Sale | −41.54K | $18.00 | $747.79K | 21.8% | 190.82K | 149.28K |
| Total | +0.00 | -$1.22M | ||||||
Stock Option (right to buy)
Common Stock
3.24K shares
Shares
−3.24K
Strike price
7.77
Held after
16.85K
Exercisable
—
Stock Option (right to buy
Common Stock
8.50K shares
Shares
−8.50K
Strike price
4.68
Held after
8.50K
Exercisable
—
Stock Option (right to buy
Common Stock
30K shares
Shares
−30K
Strike price
4.88
Held after
90K
Exercisable
—
Stock Option (right to buy
Common Stock
14.55K shares
Shares
−14.55K
Strike price
5.80
Held after
63.45K
Exercisable
—
Stock Option (right to buy
Common Stock
37.45K shares
Shares
−37.45K
Strike price
5.80
Held after
26K
Exercisable
—
Stock Option (right to buy)
Common Stock
4.10K shares
Shares
−4.10K
Strike price
7.77
Held after
12.75K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.24K shares | 4/11/2023 | M · Option Exercise | −3.24K | 7.77 | — | 16.85K |
| Stock Option (right to buy Direct | Common Stock8.50K shares | 4/11/2023 | M · Option Exercise | −8.50K | 4.68 | — | 8.50K |
| Stock Option (right to buy Direct | Common Stock30K shares | 4/11/2023 | M · Option Exercise | −30K | 4.88 | — | 90K |
| Stock Option (right to buy Direct | Common Stock14.55K shares | 4/11/2023 | M · Option Exercise | −14.55K | 5.80 | — | 63.45K |
| Stock Option (right to buy Direct | Common Stock37.45K shares | 4/12/2023 | M · Option Exercise | −37.45K | 5.80 | — | 26K |
| Stock Option (right to buy) Direct | Common Stock4.10K shares | 4/12/2023 | M · Option Exercise | −4.10K | 7.77 | — | 12.75K |